- Home
- Reagents
- Overview
- Primary Antibodies
- Overview
- Anti-Allergen Antibodies
- Anti-Coronavirus Antibodies
- Anti-Virus Antibodies
- Antibodies to Epitope Tags
- DNA/RNA Research Antibodies
- Immunotherapy Research Antibodies
- Murine Bispecific Antibody Reagents
- Neuroscience Research Antibodies
- Recombinant Antibodies from Human Patients
- Recombinant Isotype Controls
- Research-Grade Biosimilars
- Tumor Marker Antigens
- VivopureX™ Antibodies for In Vivo Research
- Secondary Antibodies
- Recombinant Proteins
- Services
- Our Technology
- About Us
- Antibody Resource
- News & Events
- How to Order
Antibody Name [Clone]
Expected Species Reactivity
Applications
-
Anti-SARS-CoV-2 and SARS-CoV nucleocapsid [mBG17]SARS-CoV, SARS-CoV-2WB, ELISA, IF
-
Anti-SARS-CoV S glycoprotein [4S1]SARS CoronavirusELISA, IF
-
Anti-SARS-CoV-2 nucleocapsid [mBG86]SARS-CoV-2WB, ELISA, IF
-
Anti-SARS-CoV S glycoprotein [A11]SARS CoronavirusWB, ELISA, IF
-
Anti-SARS-CoV S glycoprotein [Lsc18]SARS CoronavirusWB, ELISA, IF
-
Anti-SARS-CoV S glycoprotein [F26G9]SARS CoronavirusNTRL, ELISA, IF
-
Anti-SARS-CoV S glycoprotein [Ssc35]SARS CoronavirusWB, ELISA, IF
-
Anti-SARS-CoV S glycoprotein [F26G10]SARS CoronavirusNTRL, ELISA, IF
-
Anti-SARS-CoV S glycoprotein [F26G19]SARS CoronavirusNTRL, WB, ELISA, IF
-
Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]SARS-CoV-2 (COVID-19) & SARS Coronaviruscrystallography, NTRL, SPR, ELISA, IF
-
Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]SARS-CoV, SARS-CoV2ELISA, IF
-
Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]SARS-CoV, SARS-CoV2ELISA, IF
-
Anti-S protein [P17]SARS-CoV-2in vivo, neutralizing, SPR, ELISA, IF
-
Anti-Spike protein [EY6A]SARS Coronavirus 2 (SARS-Cov-2)NTRL, Surface Plasmon Resonance, therapeutic, ELISA, IF
-
Anti-Spike protein [Ty1]SARS Coronavirus 2 (SARS-Cov-2)biolayer interferometry, inhibit, NTRL, ELISA, FC, IF
-
Anti-S protein [Fab58]SARS-CoVneutralization, WB, ELISA, IF